Bone turnover and 1,25-dihydroxycholecalciferol during treatment with phosphate binders
- 1 May 1988
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 33 (5) , 989-995
- https://doi.org/10.1038/ki.1988.98
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide.BMJ, 1985
- Iliac bone histomorphometry in adults and children with osteogenesis imperfecta.Journal of Clinical Pathology, 1984
- Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.Journal of Clinical Investigation, 1984
- Aluminum Intoxication from Aluminum-Containing Phosphate Binders in Children with Azotemia Not Undergoing DialysisNew England Journal of Medicine, 1984
- Histomorphometric analysis of dynamic parameters of trabecular bone formation in the iliac crest of Normal British subjectsMetabolic Bone Disease and Related Research, 1983
- Histological Osteomalacia Due to Dietary Calcium Deficiency in ChildrenNew England Journal of Medicine, 1982
- Osteomalacia in Chronic Renal Failure: a Syndrome Previously Reported Only with Maintenance DialysisAmerican Journal of Nephrology, 1982
- Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failureKidney International, 1976
- Iatrogenic Osteomalacia and Myopathy due to Phosphate DepletionBMJ, 1974
- On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dogJournal of Clinical Investigation, 1971